Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes

Hepatology

Volumn 54, Issue 3, 2011, Pages 820-828

  Peng, Liang ^a   Xie, Dong ying ^a   Lin, Bing Liang ^a   Liu, Jing ^a   Zhu, Hai peng ^b   Xie, Chan ^a   Zheng, Yu bao ^a   Gao, Zhi Liang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b DONGGUAN PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; BILIRUBIN; GLUTATHIONE; GLYCYRRHIZIC ACID; HUMAN SERUM ALBUMIN; PROSTAGLANDIN E1; S ADENOSYLMETHIONINE;

ABDOMINAL DISTENSION; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BIOCHEMISTRY; BONE MARROW; CANCER INCIDENCE; CLINICAL TRIAL; CONTROLLED STUDY; END STAGE LIVER DISEASE; FATIGUE; FEMALE; FOLLOW UP; HEPATIC ARTERY; HEPATITIS B; HOSPITAL PATIENT; HUMAN; INCREASED APPETITE; LIVER CELL CARCINOMA; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; THERAPY EFFECT;

ADOLESCENT; ADULT; AGED; BONE MARROW CELLS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; PROGNOSIS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 80052024072     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24434     Document Type: Article

References (32)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 2002; 337: 1733-1745.
2. Liang XF, Chen YS, Wang XJ, He X, Chen LJ, Wang J, et al. A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26: 655-658.
3. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
4. Brazelton TR, Rossi FM, Keshet GI, Blau HM. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000; 290: 1775-1779.
5. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 2000; 290: 1779-1782.
6. Bayes-Genis A, Salido M, Sole Ristol F, Puig M, Brossa V, Camprecios M, et al. Host cellderived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc Res 2002; 56: 404-410.
7. Mackenzie TC, Flake AW. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 2001; 27: 601-604.
8. Le Blanc K, Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy 2005; 7: 36-45.
9. Yao P, Hu DR, Wang S, Wen W, Zhou YM, Gong LJ. Treatment of severe liver damage with autologous bone marrow stem cell transplantation in human patients [in Chinese]. Zhonghua Gan Zang Bing Za Zhi 2005; 13: 941-942.
10. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, Yarmush ML. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007; 363: 247-252.
11. + cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol 2008; 103: 1952-1958.
12. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cells injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21: 1199-1205.
13. Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl 2010; 16: 118-129.
14. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24: 2292-2298.
15. + cells in patients with chronic liver disease. Cell Prolif 2008; 41: 115-125.
16. Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakesh HR, Venkateswarlu J, et al. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc 2008; 40: 1140-1144.
17. Gao ZL, Peng L, Cong YT, Peng XM, Xie SB, Lin BL, et al. Treatment of end-stage liver diseases with bone marrow mesenchymal stem cell autotransplantation: a primary clinical study. Chin J Infect Dis 2007; 25: 181-183.
18. Lok ASF, McMahon BJ. Chronic hepatitis B: update 2009 (AASLD Practice Guidelines). HEPATOLOGY 2009; 50: 1-36.
19. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009; 3: 269-282.
20. Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles AW, Berthiaume F, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun 2007; 363: 247-252.
21. Almeida-Porada G, Zanjani ED, Porada CD. Bone marrow stem cells and liver regeneration. Exp Hematol 2010; 38: 574-580.
22. Peng L, Li H, Gu L, Peng XM, Huang YS, Gao ZL. Comparison of biological characteristics of marrow mesenchymal stem cells in hepatitis B patients and normal adults. World J Gastroenterol 2007; 13: 1743-1746.
23. Ismail A, Fouad O, Abdelnasser A, Chowdhury A, Selim A. Stem cell therapy improves the outcome of liver resection in cirrhotics. J Gastrointest Cancer 2010; 41: 17-23.
24. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol 2009; 21: 1199-1205.
25. Zhang LY, Chen X, Xu SL, Zhuang Y, Zhu CL. Dose-dependent relationship of bone marrow mesenchymal stem cells transplantation to cardiomyogenesis for functional regenerative recovery after myocardial infarction. Chin J Clin Thorac Cardiovasc Surg 2007; 6: 447-452.
26. Xiang GA, Zhang GQ, Fang CH, Gao P, Chen KY. A preliminary study of the homing capacity of allograft mesenchymal stem cells to rat liver [in Chinese]. Di Yi Jun Yi Da Xue Xue Bao 2005; 25: 994-997.
27. Hashemi S, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction. Eur Heart J 2008; 29: 251-259.
28. Peng L, Zhu HP, Zheng YB, Xie C, Chong YT, Gao ZL. Mesenchymal stem cells differentiate into hepatocyte-like cells under different induction systems in hepatitis B patients with liver failure. Afr J Biotechnol 2011; 10: 840-847.
29. Xie C, Zheng YB, Zhu HP, Peng L, Gao ZL. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro. Cell Biol Int 2009; 33: 493-500.
30. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al.; REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
31. Pan CQ, Zhang JX. Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci 2005; 2: 36-40.
32. Pei XT. Stem Cell Biology. Beijing: Science Publishers; 2003: 174.